• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$30.26 $0.27 (0.90%)

REAL-TIME: Last trade at

Dr. Reddy's Laboratories

NYSE:RDY

Jump to this page for:

Related Resources

Dr. Reddy's Laboratories Should Continue To Gain Market Share In Lucrative Markets

5/25/2012 by Seeking Alpha

The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr. Reddy's Laboratories

5/22/2012 by PR Newswire

The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr. Reddy's Laboratories - Press Releases

5/22/2012 by Zacks Investment Research

Genpact Signs Business Process Management Engagement with Dr. Reddy's Labs

5/22/2012 by Theflyonthewall.com

Genpact Signs Business Process Management Engagement with Dr. Reddy's Laboratories

5/22/2012 by StockWatch

Genpact Signs Business Process Management Engagement with Dr. Reddy's Laboratories

5/22/2012 by PR Newswire

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan

5/21/2012 by PR Newswire

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan - Press Releases

5/21/2012 by Zacks Investment Research

Dr. Reddy’s Labs (RDY) Launches Generic OTC Prevacid (NVS)

5/21/2012 by StreetInsider.com

Dr. Reddys nnounces launch of OTC Lansoprazole delayed-releas capsules

5/21/2012 by Theflyonthewall.com

Dr. Reddy’s Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules

5/21/2012 by Business Wire

Generic Versions of Plavix Get FDA Approval

5/18/2012 by InvestorPlace

Dr. Reddy’s Labs (RDY) Launches Generic Plavix Tabs (SNY)

5/18/2012 by StreetInsider.com

Dr. Reddy's Labs announces the launch of Clopidogrel tablets, USP

5/18/2012 by Theflyonthewall.com

Accumulate Dr Reddys Labs; target of Rs ...

5/18/2012 by moneycontrol.com - India

Dr. Reddy’s Announces the Launch of Clopidogrel Tablets, USP

5/18/2012 by Business Wire

Hold Dr Reddys Labs; target of Rs 1700: ...

5/16/2012 by moneycontrol.com - India

Dr. Reddy's Labs upgraded to Overweight from Neutral at JPMorgan

5/14/2012 by Theflyonthewall.com

Dr Reddys Labs - N1

5/14/2012 by moneycontrol.com - India

Dr Reddys Labs Mar '12 sales at Rs 1,788.30 crore

5/12/2012 by moneycontrol.com - India

Indian ADRs: Dr Reddys Labs down 4%, Tata Motors up 1%

5/12/2012 by moneycontrol.com - India

Dr. Reddy's Laboratories' CEO Discusses Q4 2012 Results - Earnings Call Transcript

5/11/2012 by Seeking Alpha

Dr. Reddys Labs (RDY) Reports Flat Q4 EPS of $0.40

5/11/2012 by StreetInsider.com

Dr. Reddy’s Revenues Cross $2 Billion Milestone* in FY12

5/11/2012 by Business Wire

Dr. Reddy’s Announces the Launch of Olanzapine Tablets

4/24/2012 by Business Wire

Dr. Reddy's to Release Q4 & Full Year FY12 Results on May 11, 2012

4/19/2012 by Business Wire

The Zacks Analyst Blog Highlights: AstraZeneca plc, Mylan, Teva Pharmaceuticals, Dr Reddy's Laboratories and The Bank of New York Mellon

4/3/2012 by PR Newswire

The Zacks Analyst Blog Highlights: AstraZeneca, Teva Pharmaceuticals, Mylan, Dr Reddy's Laboratories and POSCO

4/2/2012 by PR Newswire

Dr. Reddy's Laboratories Ltd. Gets Nod to Launch Generic Seroquel in US

3/28/2012 by BioSpace

Dr. Reddy’s Announces the Launch of Quetiapine Fumarate Tablets

3/28/2012 by Business Wire

FDA to Inspect Dr. Reddy's Laboratories Ltd.'s Plant in Mexico

3/20/2012 by BioSpace

Dr. Reddy’s Announces the Launch of Ziprasidone Hydrochloride Capsules

3/3/2012 by Business Wire

Top Analyst Upgrades & Downgrades (NLY, MT, BP, CBOE, DMD, RDY, ING, MS, NOV, OPEN, SOHU, UBS, VSH, YUM)

2/8/2012 by 24/7 Wall Street

Credit Suisse Downgrades Dr. Reddy's Laboratories (RDY) to Neutral

2/7/2012 by StreetInsider.com

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca

2/7/2012 by PR Newswire

Dr. Reddy's Laboratories' CEO Discusses Q3 2012 Results - Earnings Call Transcript

2/3/2012 by Seeking Alpha

Dr. Reddys Labs (RDY) Reports Q3 Earnings of $0.60

2/3/2012 by StreetInsider.com

Dr. Reddy’s Q3 FY12 Financial Results

2/3/2012 by Business Wire

Dr. Reddy’s Laboratories (RDY) Comments on Recent Media Reports

1/27/2012 by StreetInsider.com

Dr. Reddy’s Clarifies Media Reports

1/27/2012 by Business Wire
See More Articles...